Eventually, 10 potential TAA targets were investigated from 75 HCC driver genes, including p16, SETDB1, RNA helicase A, BRG1, GNAS, Merlin, DNMT3A, NRAS, GMPS, and ERK2 (Table 2). The gene discussed is SMARCA4; the disease is hepatocellular carcinoma.